南方医科大学学报 ›› 2025, Vol. 45 ›› Issue (11): 2511-2517.doi: 10.12122/j.issn.1673-4254.2025.11.24
• • 上一篇
陈丽红1,2(
), 陈雅芬1,2(
), 谢惠琳1,2, 黄彦诚1,2, 黄雅彬1,2, 靳三庆1,2(
)
收稿日期:2025-08-10
出版日期:2025-11-20
发布日期:2025-11-28
通讯作者:
靳三庆
E-mail:chenlihn@mail.sysu.edu.cn;chenyf399@mail.sysu.edu.cn;jinsq@mail.sysu.edu.cn
作者简介:陈丽红,博士,主治医师,E-mail: chenlihn@mail.sysu.edu.cn基金资助:
Lihong CHEN1,2(
), Yafen CHEN1,2(
), Huilin XIE1,2, Yancheng HUANG1,2, Yabin HUANG1,2, Sanqing JIN1,2(
)
Received:2025-08-10
Online:2025-11-20
Published:2025-11-28
Contact:
Sanqing JIN
E-mail:chenlihn@mail.sysu.edu.cn;chenyf399@mail.sysu.edu.cn;jinsq@mail.sysu.edu.cn
摘要:
目的 探讨神经监测气管导管(EMG导管)与普通钢丝加强型气管导管(CWR导管)对全身麻醉下行甲状腺手术患者术后咽喉痛(POST)发生率的影响,并分析其相关危险因素。 方法 本研究为回顾性队列研究,收集2024年10月~2025年3月于中山大学附属第六医院接受择期甲状腺手术的245例全麻患者的临床资料,根据术中所用气管导管类型,将患者分为EMG组(n=100)和CWR组(n=145),比较两组POST及其他并发症的发生情况。为控制潜在混杂因素,采用倾向性评分匹配(PSM)方法对两组进行基线特征调整,匹配后进一步采用多因素Logistic回归分析,筛选影响POST发生的独立危险因素。 结果 初步基线资料比较显示,EMG组与CWR组在部分变量上存在统计学差异(P<0.05),经PSM匹配后共纳入165例患者(EMG组90例,CWR组75例),两组基线特征差异均无统计学意义(P>0.05),具有可比性。匹配后分析结果显示,EMG组手术时长较CWR组缩短(P=0.002),但POST发生率升高(P=0.001)。多因素Logistic回归分析结果显示,术中使用EMG导管(OR=17.50,95% CI: 2.25~136.03,P<0.01)是POST发生的独立危险因素。 结论 EMG导管在甲状腺手术中有助于缩短手术时间并实现喉返神经功能保护,但其特殊结构可能增加术后咽喉痛的发生风险。临床应用中应权衡神经保护与患者术后舒适度,合理选择导管类型及优化插管策略,以提升患者围术期体验。
陈丽红, 陈雅芬, 谢惠琳, 黄彦诚, 黄雅彬, 靳三庆. 全身麻醉下甲状腺切除术中应用神经监测气管导管会增加术后咽喉痛的发生风险:一项回顾性队列研究[J]. 南方医科大学学报, 2025, 45(11): 2511-2517.
Lihong CHEN, Yafen CHEN, Huilin XIE, Yancheng HUANG, Yabin HUANG, Sanqing JIN. Intubaiton with electromyographic endotracheal tube increases risks of postoperative sore throat following thyroidectomy under general anesthesia: a retrospective cohort study[J]. Journal of Southern Medical University, 2025, 45(11): 2511-2517.
| Variable | Before PSM | After PSM | ||||
|---|---|---|---|---|---|---|
| EMG group (n=100) | CWR group (n=145) | P | EMG group (n=90) | CWR group (n=75) | P | |
| Age (year) | 44.31±13.15 | 46.18±12.96 | 0.271 | 44.87±12.99 | 45.44±13.88 | 0.785 |
| BMI (kg/m²) | 24.05±4.24 | 24.19±4.42 | 0.804 | 24.20±4.28 | 24.21±5.32 | 0.989 |
| Height (cm) | 161.38±8.05 | 159.26±20.07 | 0.318 | 160.95±7.82 | 158.74±19.62 | 0.329 |
| Weight (kg) | 62.85±13.12 | 63.24±13.02 | 0.816 | 62.95±13.32 | 62.87±14.89 | 0.972 |
| Gender (n, %) | 0.697 | 0.658 | ||||
| Male | 22 (22.00) | 35 (24.14) | 19 (21.11) | 18 (24.00) | ||
| Female | 78 (78.00) | 110 (75.86) | 71 (78.89) | 57 (76.00) | ||
| Preoperative diagnosis (n, %) | 0.037 | 0.813 | ||||
| Hashimoto's thyroiditis | 1 (1.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | ||
| Thyroid mass | 87 (87.00) | 112 (77.24) | 80 (88.89) | 64 (85.33) | ||
| Thyroid nodule | 10 (10.00) | 31 (21.38) | 9 (10.00) | 10 (13.33) | ||
| Hyperthyroidism | 2 (2.00) | 2 (1.38) | 1 (1.11) | 1 (1.33) | ||
| ASA physical status (n, %) | 0.073 | 0.806 | ||||
| Class I | 14 (14.00) | 10 (6.90) | 10 (11.11) | 6 (8.00) | ||
| Class II | 82 (82.00) | 125 (86.21) | 77 (85.56) | 67 (89.33) | ||
| Class III | 3 (3.00) | 10 (6.90) | 3 (3.33) | 2 (2.67) | ||
| Class IV | 1 (1.00) | 0 (0.00) | ||||
| Comorbidities (n, %) | 0.380 | 0.652 | ||||
| None | 87 (87.00) | 119 (82.07) | 77 (85.56) | 66 (88.00) | ||
| Hypertension | 7 (7.00) | 18 (12.41) | 7 (7.78) | 5 (6.67) | ||
| Diabetes | 4 (4.00) | 3 (2.07) | 4 (4.44) | 1 (1.33) | ||
| Hyperthyroidism | 2 (2.00) | 5 (3.45) | 2 (2.22) | 3 (4.00) | ||
| Surgical approach (n, %) | 0.715 | 0.756 | ||||
| Transoral endoscopic | 3 (3.00) | 2 (1.38) | 3 (3.33) | 1 (1.33) | ||
| Transaxillary endoscopic | 7 (7.00) | 11 (7.59) | 6 (6.67) | 5 (6.67) | ||
| Open surgery | 90 (90.00) | 132 (91.03) | 81 (90.00) | 69 (92.00) | ||
| Extent of thyroidectomy (n, %) | <0.001 | 0.113 | ||||
| Total thyroidectomy | 20 (20.00) | 66 (45.52) | 19 (21.11) | 24 (32.00) | ||
| Subtotal thyroidectomy | 80 (80.00) | 79 (54.48) | 71 (78.89) | 51 (68.00) | ||
| Preoperative voice change (n, %) | 0.892 | 0.873 | ||||
| Yes | 1 (1.00) | 3 (2.07) | 1 (1.11) | 2 (2.67) | ||
| No | 99 (99.00) | 142 (97.93) | 89 (98.89) | 73 (97.33) | ||
| Intraoperative steroid use (n, %) | 0.403 | 0.140 | ||||
| No | 80 (80.00) | 122 (84.14) | 70 (77.78) | 65 (86.67) | ||
| Yes | 20 (20.00) | 23 (15.86) | 20 (22.22) | 10 (13.33) | ||
| Postoperative budesonide dose (mg) | 6.00 (4.00, 6.00) | 6.00 (6.00, 8.00) | 0.003 | 6.00 (4.00, 6.00) | 6.00 (4.00,8.00) | 0.372 |
表1 倾向性评分匹配(PSM)前后两组患者的基线资料
Tab.1 Baseline characteristics of patients in the two groups before and after propensity score matching (PSM)
| Variable | Before PSM | After PSM | ||||
|---|---|---|---|---|---|---|
| EMG group (n=100) | CWR group (n=145) | P | EMG group (n=90) | CWR group (n=75) | P | |
| Age (year) | 44.31±13.15 | 46.18±12.96 | 0.271 | 44.87±12.99 | 45.44±13.88 | 0.785 |
| BMI (kg/m²) | 24.05±4.24 | 24.19±4.42 | 0.804 | 24.20±4.28 | 24.21±5.32 | 0.989 |
| Height (cm) | 161.38±8.05 | 159.26±20.07 | 0.318 | 160.95±7.82 | 158.74±19.62 | 0.329 |
| Weight (kg) | 62.85±13.12 | 63.24±13.02 | 0.816 | 62.95±13.32 | 62.87±14.89 | 0.972 |
| Gender (n, %) | 0.697 | 0.658 | ||||
| Male | 22 (22.00) | 35 (24.14) | 19 (21.11) | 18 (24.00) | ||
| Female | 78 (78.00) | 110 (75.86) | 71 (78.89) | 57 (76.00) | ||
| Preoperative diagnosis (n, %) | 0.037 | 0.813 | ||||
| Hashimoto's thyroiditis | 1 (1.00) | 0 (0.00) | 0 (0.00) | 0 (0.00) | ||
| Thyroid mass | 87 (87.00) | 112 (77.24) | 80 (88.89) | 64 (85.33) | ||
| Thyroid nodule | 10 (10.00) | 31 (21.38) | 9 (10.00) | 10 (13.33) | ||
| Hyperthyroidism | 2 (2.00) | 2 (1.38) | 1 (1.11) | 1 (1.33) | ||
| ASA physical status (n, %) | 0.073 | 0.806 | ||||
| Class I | 14 (14.00) | 10 (6.90) | 10 (11.11) | 6 (8.00) | ||
| Class II | 82 (82.00) | 125 (86.21) | 77 (85.56) | 67 (89.33) | ||
| Class III | 3 (3.00) | 10 (6.90) | 3 (3.33) | 2 (2.67) | ||
| Class IV | 1 (1.00) | 0 (0.00) | ||||
| Comorbidities (n, %) | 0.380 | 0.652 | ||||
| None | 87 (87.00) | 119 (82.07) | 77 (85.56) | 66 (88.00) | ||
| Hypertension | 7 (7.00) | 18 (12.41) | 7 (7.78) | 5 (6.67) | ||
| Diabetes | 4 (4.00) | 3 (2.07) | 4 (4.44) | 1 (1.33) | ||
| Hyperthyroidism | 2 (2.00) | 5 (3.45) | 2 (2.22) | 3 (4.00) | ||
| Surgical approach (n, %) | 0.715 | 0.756 | ||||
| Transoral endoscopic | 3 (3.00) | 2 (1.38) | 3 (3.33) | 1 (1.33) | ||
| Transaxillary endoscopic | 7 (7.00) | 11 (7.59) | 6 (6.67) | 5 (6.67) | ||
| Open surgery | 90 (90.00) | 132 (91.03) | 81 (90.00) | 69 (92.00) | ||
| Extent of thyroidectomy (n, %) | <0.001 | 0.113 | ||||
| Total thyroidectomy | 20 (20.00) | 66 (45.52) | 19 (21.11) | 24 (32.00) | ||
| Subtotal thyroidectomy | 80 (80.00) | 79 (54.48) | 71 (78.89) | 51 (68.00) | ||
| Preoperative voice change (n, %) | 0.892 | 0.873 | ||||
| Yes | 1 (1.00) | 3 (2.07) | 1 (1.11) | 2 (2.67) | ||
| No | 99 (99.00) | 142 (97.93) | 89 (98.89) | 73 (97.33) | ||
| Intraoperative steroid use (n, %) | 0.403 | 0.140 | ||||
| No | 80 (80.00) | 122 (84.14) | 70 (77.78) | 65 (86.67) | ||
| Yes | 20 (20.00) | 23 (15.86) | 20 (22.22) | 10 (13.33) | ||
| Postoperative budesonide dose (mg) | 6.00 (4.00, 6.00) | 6.00 (6.00, 8.00) | 0.003 | 6.00 (4.00, 6.00) | 6.00 (4.00,8.00) | 0.372 |
| Variable | EMG group (n=90) | CWR group (n=75) | P |
|---|---|---|---|
| Duration of surgery (min) | 85.41±33.35 | 102.79±38.96# | 0.002 |
| Duration of anesthesia (min ) | 152.47±37.89 | 152.28±41.51 | 0.976 |
| Postoperative hospital stay (day) | 3.31±1.15 | 3.64±0.98 | 0.052 |
| Sore throat after surgery (n, %) | 17 (18.89) | 2 (2.67)# | 0.001 |
| Incisional pain after surgery (n, %) | 66 (73.33) | 58 (77.33) | 0.554 |
| Recurrent laryngeal nerve injury (n, %) | 0 (0.00) | 0 (0.00) | - |
| Postoperative voice change (n, %) | 5 (5.75) | 3 (4.05) | 0.921 |
表2 两组患者的手术情况及术后情况
Tab.2 Intraoperative and postoperative outcomes of the patients in the two groups
| Variable | EMG group (n=90) | CWR group (n=75) | P |
|---|---|---|---|
| Duration of surgery (min) | 85.41±33.35 | 102.79±38.96# | 0.002 |
| Duration of anesthesia (min ) | 152.47±37.89 | 152.28±41.51 | 0.976 |
| Postoperative hospital stay (day) | 3.31±1.15 | 3.64±0.98 | 0.052 |
| Sore throat after surgery (n, %) | 17 (18.89) | 2 (2.67)# | 0.001 |
| Incisional pain after surgery (n, %) | 66 (73.33) | 58 (77.33) | 0.554 |
| Recurrent laryngeal nerve injury (n, %) | 0 (0.00) | 0 (0.00) | - |
| Postoperative voice change (n, %) | 5 (5.75) | 3 (4.05) | 0.921 |
| Variable | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| OR (95% CI) | P | OR (95% CI) | P | |
| Age (year) | 1.00 (0.97-1.04) | 0.948 | - | - |
| Female (Ref: Male) | 2.68 (0.59-12.18) | 0.202 | - | - |
| BMI (kg/m²) | 0.97 (0.86-1.09) | 0.583 | - | - |
| Preoperative diagnosis (Ref: Thyroid mass) | ||||
| Thyroid nodule | 0.89 (0.19-4.17) | 0.878 | - | - |
| Hyperthyroidism | 0.00 (0.00-Inf) | 0.993 | - | - |
| EMG tube (Ref: CWR tube) | 8.50 (1.90-38.12) | 0.005 | 17.56 (2.26-136.52) | 0.006 |
| Surgical approach (Ref: Transoral) | ||||
| Transaxillary | 0.67 (0.04-10.25) | 0.771 | - | - |
| Open surgery | 0.36 (0.04-3.68) | 0.390 | - | - |
| Subtotal thyroidectomy(vs total) | 0.99 (0.33-2.92) | 0.979 | - | - |
| Operation time (min) | 1.00 (0.99-1.01) | 0.910 | - | - |
| Anesthesia duration (min) | 1.00 (0.99-1.02) | 0.549 | - | - |
| Intraoperative steroid use (Ref: No) | 0.50 (0.11-2.27) | 0.366 | - | - |
| Postoperative budesonide dose (mg) | 1.23 (1.01-1.50) | 0.047 | 1.24 (1.01-1.52) | 0.046 |
表3 术后咽喉痛的单因素与多因素Logistic回归分析结果
Tab 3 Univariate and multivariate logistic regression analysis of the factors associated with postoperative sore throat
| Variable | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|
| OR (95% CI) | P | OR (95% CI) | P | |
| Age (year) | 1.00 (0.97-1.04) | 0.948 | - | - |
| Female (Ref: Male) | 2.68 (0.59-12.18) | 0.202 | - | - |
| BMI (kg/m²) | 0.97 (0.86-1.09) | 0.583 | - | - |
| Preoperative diagnosis (Ref: Thyroid mass) | ||||
| Thyroid nodule | 0.89 (0.19-4.17) | 0.878 | - | - |
| Hyperthyroidism | 0.00 (0.00-Inf) | 0.993 | - | - |
| EMG tube (Ref: CWR tube) | 8.50 (1.90-38.12) | 0.005 | 17.56 (2.26-136.52) | 0.006 |
| Surgical approach (Ref: Transoral) | ||||
| Transaxillary | 0.67 (0.04-10.25) | 0.771 | - | - |
| Open surgery | 0.36 (0.04-3.68) | 0.390 | - | - |
| Subtotal thyroidectomy(vs total) | 0.99 (0.33-2.92) | 0.979 | - | - |
| Operation time (min) | 1.00 (0.99-1.01) | 0.910 | - | - |
| Anesthesia duration (min) | 1.00 (0.99-1.02) | 0.549 | - | - |
| Intraoperative steroid use (Ref: No) | 0.50 (0.11-2.27) | 0.366 | - | - |
| Postoperative budesonide dose (mg) | 1.23 (1.01-1.50) | 0.047 | 1.24 (1.01-1.52) | 0.046 |
| [1] | Seo JH, Cho CW, Hong DM, et al. The effects of thermal softening of double-lumen endobronchial tubes on postoperative sore throat, hoarseness and vocal cord injuries: a prospective double-blind randomized trial[J]. Br J Anaesth, 2016, 116(2): 282-8. doi:10.1093/bja/aev414 |
| [2] | Wang G, Qi Y, Wu LN, et al. Comparative efficacy of 6 topical pharmacological agents for preventive interventions of postoperative sore throat after tracheal intubation: a systematic review and network meta-analysis[J]. Anesth Analg, 2021, 133(1): 58-67. doi:10.1213/ane.0000000000005521 |
| [3] | Singh G, Puri A. In ear surgeries intravenous dexamethasone preoperatively decreases post operative sore throat after endotracheal intubation in adult patients: a prospective randomized control study[J]. Indian J Otolaryngol Head Neck Surg, 2021, 73(1): 1-5. doi:10.1007/s12070-019-01776-x |
| [4] | Ryu JH, Han SS, Do SH, et al. Effect of adjusted cuff pressure of endotracheal tube during thyroidectomy on postoperative airway complications: prospective, randomized, and controlled trial[J]. World J Surg, 2013, 37(4): 786-91. doi:10.1007/s00268-013-1908-x |
| [5] | Gong YH, Xu XH, Wang J, et al. Laryngeal mask airway reduces incidence of post-operative sore throat after thyroid surgery compared with endotracheal tube: a single-blinded randomized controlled trial[J]. BMC Anesthesiol, 2020, 20(1): 16. doi:10.1186/s12871-020-0932-2 |
| [6] | Jung TH, Rho JH, Hwang JH, et al. The effect of the humidifier on sore throat and cough after thyroidectomy[J]. Korean J Anesthesiol, 2011, 61(6): 470-4. doi:10.4097/kjae.2011.61.6.470 |
| [7] | Zhang DQ, Pino A, Caruso E, et al. Neural monitoring in thyroid surgery is here to stay[J]. Gland Surg, 2020, 9(): S43-6. doi:10.21037/gs.2019.10.24 |
| [8] | Saxe A, Idris M, Gemechu J. Does the use of intraoperative neuromonitoring during thyroid and parathyroid surgery reduce the incidence of recurrent laryngeal nerve injuries? a systematic review and meta-analysis[J]. Diagnostics (Basel), 2024, 14(9): 860. doi:10.3390/diagnostics14090860 |
| [9] | Ji SW, Hu MR, Zhang CJ, et al. Systematic review with meta-analysis of intraoperative neuromonitoring during thyroid reoperation[J]. Pak J Med Sci, 2024, 40(8): 1860-6. doi:10.12669/pjms.40.8.8241 |
| [10] | Aygun N, Kostek M, Isgor A, et al. Anatomical, functional, and dynamic evidences obtained by intraoperative neuromonitoring improving the standards of thyroidectomy[J]. Sisli Etfal Hastan Tip Bul, 2021, 55(2): 146-55. |
| [11] | El-Boghdadly K, Bailey CR, Wiles MD. Postoperative sore throat: a systematic review[J]. Anaesthesia, 2016, 71(6): 706-17. doi:10.1111/anae.13438 |
| [12] | Chen ZP, Zuo ZX, Zhang L, et al. Postoperative sore throat after tracheal intubation: an updated narrative review and call for action[J]. J Pain Res, 2025, 18: 2285-306. doi:10.2147/jpr.s498933 |
| [13] | Mazzotta E, Soghomonyan S, Hu LQ. Postoperative sore throat: prophylaxis and treatment[J]. Front Pharmacol, 2023, 14: 1284071. doi:10.3389/fphar.2023.1284071 |
| [14] | Park SH, Han SH, Do SH, et al. Prophylactic dexamethasone decreases the incidence of sore throat and hoarseness after tracheal extubation with a double-lumen endobronchial tube[J]. Anesth Analg, 2008, 107(6): 1814-8. doi:10.1213/ane.0b013e318185d093 |
| [15] | Liu X, Cheng ZL, Chen XX, et al. A neural integrity monitor electromyography endotracheal tube causes more severe postoperative sore throat than a standard endotracheal tube in adults: a prospective cohort study[J]. World J Surg, 2023, 47(10): 2409-15. doi:10.1007/s00268-023-07092-4 |
| [16] | Chen HC, Lu ZJ. Effects of intraoperative neuromonitoring (IONM) technology on early recovery quality in patients after thyroid surgery: a randomized controlled trial[J]. PLoS One, 2023, 18(9): e0292036. doi:10.1371/journal.pone.0292036 |
| [17] | Moon J, Kim JK, Shin HJ, et al. Effects of endotracheal tube with adhesive superficial laryngeal electrodes for intraoperative nerve monitoring on laryngopharyngeal complications during thyroidectomy[J]. Biomedicines, 2023, 11(9): 2544. doi:10.3390/biomedicines11092544 |
| [18] | Zhao YS, Wang PY, Dionigi G, et al. Utilization of recurrent laryngeal nerve monitoring during thyroid surgery in China: a point prevalence survey (2015-2023)[J]. Int J Surg, 2025, 111(1): 439-49. doi:10.1097/js9.0000000000002084 |
| [19] | Dralle H, Sekulla C, Lorenz K, et al. Loss of the nerve monitoring signal during bilateral thyroid surgery[J]. Br J Surg, 2012, 99(8): 1089-95. doi:10.1002/bjs.8831 |
| [20] | Liddy W, Wu CW, Dionigi G, et al. Varied recurrent laryngeal nerve course is associated with increased risk of nerve dysfunction during thyroidectomy: results of the surgical anatomy of the recurrent laryngeal nerve in thyroid surgery study, an international multicenter prospective anatomic and electrophysiologic study of 1000 monitored nerves at risk from the international neural monitoring study group[J]. Thyroid, 2021, 31(11): 1730-40. doi:10.1089/thy.2021.0155 |
| [21] | Abdelhamid A, Aspinall S. Intraoperative nerve monitoring in thyroid surgery: analysis of United Kingdom registry of endocrine and thyroid surgery database[J]. Br J Surg, 2021, 108(2): 182-7. doi:10.1093/bjs/znaa081 |
| [22] | Kim DH, Kim SW, Hwang SH. Intraoperative neural monitoring for early vocal cord function assessment after thyroid surgery: a systematic review and meta-analysis[J]. World J Surg, 2021, 45(11): 3320-7. doi:10.1007/s00268-021-06225-x |
| [23] | Bai BL, Chen WZ. Protective effects of intraoperative nerve monitoring (IONM) for recurrent laryngeal nerve injury in thyroidectomy: meta-analysis[J]. Sci Rep, 2018, 8(1): 7761. doi:10.1038/s41598-018-26219-5 |
| [24] | Kale O, Akaslan F, Keskin G, et al. Frequency of side effects experienced in two different NIM-EMG tubes used in thyroid and parathyroid surgery; a prospective observational study[J]. BMC Anesthesiol, 2024, 24(1): 253. doi:10.1186/s12871-024-02643-1 |
| [25] | Hu BJ, Bao R, Wang XL, et al. The size of endotracheal tube and sore throat after surgery: a systematic review and meta-analysis[J]. PLoS One, 2013, 8(10): e74467. doi:10.1371/journal.pone.0074467 |
| [26] | Chandler M. Tracheal intubation and sore throat: a mechanical explanation[J]. Anaesthesia, 2002, 57(2): 155-61. doi:10.1046/j.1365-2044.2002.02329.x |
| [27] | Hisham AN, Roshilla H, Amri N, et al. Post-thyroidectomy sore throat following endotracheal intubation[J]. ANZ J Surg, 2001, 71(11): 669-71. doi:10.1046/j.1445-1433.2001.02230.x |
| [28] | Farrow S, Farrow C, Soni N. Size matters: choosing the right tracheal tube[J]. Anaesthesia, 2012, 67(8): 815-9. doi:10.1111/j.1365-2044.2012.07250.x |
| [29] | Xu YJ, Wang SL, Ren Y, et al. A smaller endotracheal tube combined with intravenous lidocaine decreases post-operative sore throat - a randomized controlled trial[J]. Acta Anaesthesiol Scand, 2012, 56(10): 1314-20. doi:10.1111/j.1399-6576.2012.02768.x |
| [30] | Cho HY, Yang SM, Jung CW, et al. A randomised controlled trial of 7.5-mm and 7.0-mm tracheal tubes vs. 6.5-mm and 6.0-mm tracheal tubes for men and women during laparoscopic surgery[J]. Anaesthesia, 2022, 77(1): 54-8. doi:10.1111/anae.15568 |
| [31] | Stout DM, Bishop MJ, Dwersteg JF, et al. Correlation of endotracheal tube size with sore throat and hoarseness following general anesthesia[J]. Anesthesiology, 1987, 67(3): 419-21. doi:10.1097/00000542-198709000-00025 |
| [32] | Rajan S, Narayani N, Paul J, et al. Effect of intracuff dexamethasone on incidence and severity of post operative sore-Prospective randomized study[J]. J Anaesthesiol Clin Pharmacol, 2021, 37(1): 114-8. doi:10.4103/joacp.joacp_28_19 |
| [33] | Kheirabadi D, Ardekani MS, Honarmand A, et al. Comparison prophylactic effects of gargling different doses of ketamine on attenuating postoperative sore throat: a single-blind randomized controlled trial[J]. Int J Prev Med, 2021, 12: 62. doi:10.4103/ijpvm.ijpvm_147_19 |
| [34] | Zhu GL, Wang X, Cao XY, et al. The effect of different endotracheal tube cuff pressure monitoring systems on postoperative sore throat in patients undergoing tracheal intubation: a randomized clinical trial[J]. BMC Anesthesiol, 2024, 24(1): 115. doi:10.1186/s12871-024-02499-5 |
| [35] | Lee SH, Lee YC, Lee JH, et al. The prophylactic effect of dexamethasone on postoperative sore throat in prone position surgery[J]. Korean J Anesthesiol, 2016, 69(3): 255-61. doi:10.4097/kjae.2016.69.3.255 |
| [36] | Kuriyama A, Maeda H, Sun R. Aerosolized corticosteroids to prevent postoperative sore throat in adults: a systematic review and meta-analysis[J]. Acta Anaesthesiol Scand, 2019, 63(3): 282-91. doi:10.1111/aas.13275 |
| [37] | Bagchi D, Mandal MC, Das S, et al. Efficacy of intravenous dexamethasone to reduce incidence of postoperative sore throat: a prospective randomized controlled trial[J]. J Anaesthesiol Clin Pharmacol, 2012, 28(4): 477-80. doi:10.4103/0970-9185.101920 |
| [38] | Chen PP, Zhang X, Ye H, et al. Effects of preoperative inhaled budesonide combined with intravenous dexamethasone on postoperative sore throat in patients who underwent thyroidectomy: a randomized controlled trial[J]. Medicine (Baltimore), 2024, 103(20): e38235. doi:10.1097/md.0000000000038235 |
| [39] | Snyder SK, Lairmore TC, Hendricks JC, et al. Elucidating mechanisms of recurrent laryngeal nerve injury during thyroidectomy and parathyroidectomy[J]. J Am Coll Surg, 2008, 206(1): 123-30. doi:10.1016/j.jamcollsurg.2007.07.017 |
| [40] | Biro P, Seifert B, Pasch T. Complaints of sore throat after tracheal intubation: a prospective evaluation[J]. Eur J Anaesthesiol, 2005, 22(4): 307-11. doi:10.1017/s0265021505000529 |
| [41] | Puri A, Ghosh SK, Singh G, et al. Gargling with ketamine preoperatively decreases postoperative sore throat after endotracheal intubation in middle ear surgeries: a prospective randomized control study[J]. Indian J Otolaryngol Head Neck Surg, 2022, 74(): 5739-43. doi:10.1007/s12070-021-03062-1 |
| [1] | 陈永杰, 王 博, 姚 兰, 冯泽国. 米库氯铵持续输注用于全凭静脉麻醉下甲状腺手术的最大剂量:30例神经功能监测的序贯试验[J]. 南方医科大学学报, 2021, 41(1): 64-68. |
| [2] | 王加芳,卢 凡,周明星,戚 忠,陈治军. 重型和危重型COVID-19患者实施气管插管的临床经验[J]. 南方医科大学学报, 2020, 40(03): 337-341. |
| [3] | 陈永杰,黄连军,李扬,仝黎,王晓晨,胡克石,冯泽国. 序贯法测定持续输注米库氯铵用于甲状腺手术神经监测的最大剂量[J]. 南方医科大学学报, 2018, 38(12): 1472-. |
| [4] | 陈平雁1, 刘理2, 刘定立3, 莫一心1, 张超1, 欧春泉1, 王淑平1, 杨海青1, 安胜利1. SARS患者的体温变化规律及临床对照研究[J]. 南方医科大学学报, 2005, 25(09): 1095-1099. |
| 阅读次数 | ||||||
|
全文 |
|
|||||
|
摘要 |
|
|||||